StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Bionano Genomics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before. The highest annual figure on record is $20.08M in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$16.33M-18.7%
FY2019Dec 31, 2019$20.08M+122.4%
FY2018Dec 31, 2018$9.03M+34.2%
FY2017Dec 31, 2017$6.73M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$0-100.0%
Q1 FY2021Mar 31, 2021$14.87M-12.4%
Q4 FY2020Dec 31, 2020$16.33M-18.7%
Q3 FY2020Sep 30, 2020$16.01M-14.7%
Q2 FY2020Jun 30, 2020$15.71M-15.6%
Q1 FY2020Mar 31, 2020$16.97M-7.7%
Q4 FY2019Dec 31, 2019$20.08M+122.4%
Q3 FY2019Sep 30, 2019$18.78M+108.4%
Q2 FY2019Jun 30, 2019$18.62M+176.7%
Q1 FY2019Mar 31, 2019$18.38M–
Q4 FY2018Dec 31, 2018$9.03M–
Q3 FY2018Sep 30, 2018$9.01M–
Q4 FY2017Dec 31, 2017$6.73M–

More Bionano Genomics figures

See a number that looks wrong?